These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 4880517)

  • 21. [Rational bases for the treatment of osteoporosis].
    Adami S; Bianchini D; Zanfisi C; Fracassi E; Galvanini G
    Ann Ital Med Int; 1995 Oct; 10 Suppl():18S-21S. PubMed ID: 8562260
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The contribution of bone histology to understanding the pathogenesis and improving the management of osteoporosis.
    Parfitt AM
    Clin Invest Med; 1982; 5(2-3):163-7. PubMed ID: 7116722
    [No Abstract]   [Full Text] [Related]  

  • 23. Osteoporosis of hematologic etiology.
    Gurevitch O; Khitrin S; Valitov A; Slavin S
    Exp Hematol; 2007 Jan; 35(1):128-36. PubMed ID: 17198881
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An evaluation of several biochemical markers for bone formation and resorption in a protocol utilizing cyclical parathyroid hormone and calcitonin therapy for osteoporosis.
    Hodsman AB; Fraher LJ; Ostbye T; Adachi JD; Steer BM
    J Clin Invest; 1993 Mar; 91(3):1138-48. PubMed ID: 8450043
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of osteoporosis: theoretical possibilities.
    Parfitt AM
    Clin Invest Med; 1982; 5(2-3):181-3. PubMed ID: 7116724
    [No Abstract]   [Full Text] [Related]  

  • 26. The mineralization of bone tissue: a forgotten dimension in osteoporosis research.
    Boivin G; Meunier PJ
    Osteoporos Int; 2003; 14 Suppl 3():S19-24. PubMed ID: 12730799
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of osteoporosis].
    Haas HG
    Bol Inf Col Odontol Estomatol (Barc); 1969 Dec; 14(101):13-6. PubMed ID: 5266686
    [No Abstract]   [Full Text] [Related]  

  • 28. Parathyroid hormone: a double-edged sword for bone metabolism.
    Qin L; Raggatt LJ; Partridge NC
    Trends Endocrinol Metab; 2004 Mar; 15(2):60-5. PubMed ID: 15036251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Physiological bases of bone regeneration II. The remodeling process.
    Fernández-Tresguerres-Hernández-Gil I; Alobera-Gracia MA; del-Canto-Pingarrón M; Blanco-Jerez L
    Med Oral Patol Oral Cir Bucal; 2006 Mar; 11(2):E151-7. PubMed ID: 16505794
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systemic assessments utilizing saliva: part 2 osteoporosis and use of saliva to measure bone turnover.
    Koka S; Forde MD; Khosla S
    Int J Prosthodont; 2006; 19(1):53-60. PubMed ID: 16479761
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Studies of internal remodeling of bones].
    Lacroix P
    Arch Biol (Liege); 1970; 81(2):275-304. PubMed ID: 5516878
    [No Abstract]   [Full Text] [Related]  

  • 32. [Cytokines and osteoporosis].
    Jørgensen NR
    Ugeskr Laeger; 1997 Dec; 160(1):24-8. PubMed ID: 9446261
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Antiresorptive therapy for osteoporosis and bone quality].
    Kishimoto H
    Clin Calcium; 2005 Jun; 15(6):1007-11. PubMed ID: 15930715
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bone histodynamic changes in the rheumatic diseases.
    Duncan H
    Clin Orthop Relat Res; 1966; 49():125-34. PubMed ID: 5962612
    [No Abstract]   [Full Text] [Related]  

  • 35. [Biochemical markers of bone remodeling: pre-analytical variations and guidelines for their use. SFBC (Société Française de Biologie Clinique) Work Group. Biochemical markers of bone remodeling].
    Garnero P; Bianchi F; Carlier MC; Genty V; Jacob N; Kamel S; Kindermans C; Plouvier E; Pressac M; Souberbielle JC
    Ann Biol Clin (Paris); 2000; 58(6):683-704. PubMed ID: 11098165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bone markers: biochemical and clinical significance.
    Lello S; Paoletti AM; Migliaccio S; Melis GB
    Aging Clin Exp Res; 2004 Jun; 16 Suppl(3):33-6. PubMed ID: 15506699
    [No Abstract]   [Full Text] [Related]  

  • 37. Fucoidan promotes osteoblast differentiation via JNK- and ERK-dependent BMP2-Smad 1/5/8 signaling in human mesenchymal stem cells.
    Kim BS; Kang HJ; Park JY; Lee J
    Exp Mol Med; 2015 Jan; 47(1):e128. PubMed ID: 25572360
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bone remodeling and balance and the development of osteoporosis.
    Epker BN
    Parodontol Acad Rev; 1968 Oct; 2(3):125-35. PubMed ID: 4880517
    [No Abstract]   [Full Text] [Related]  

  • 39. Bone remodeling and balance and the development of osteoporosis.
    Epker BN
    Annu Meet Am Inst Oral Biol; 1967; ():3-15. PubMed ID: 5236303
    [No Abstract]   [Full Text] [Related]  

  • 40. Physiology and pathology of bone remodeling. Cellular basis of bone structure in health and in osteoporosis.
    Jaworski ZF
    Orthop Clin North Am; 1981 Jul; 12(3):485-512. PubMed ID: 7290586
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.